Molecular Tumor Boards: Uniting Experts to Guide Precision Therapies
Vanderbilt Researchers at #ANA2019 in St. Louis, Missouri
The Vanderbilt Department of Neurology is excited to share their insights at the 144th annual meeting of the American Neurological Association.
Microbial Small RNA’s Role in Atherosclerosis
New research will explore impact on cardiovascular risk under acceptable LDL levels.
Insulin Resistance Centers on Dosing Strategy, Not Hyperglycemia
Study of distinct populations helps reveal main causes.
Reducing Opioid Prescriptions After Cesarean Birth
New research and a new tool to help predict outpatient needs.
Support for Biologics for Ankylosing, Axial Spondyloarthritis
ACR guidelines include TNF and IL inhibitors as second-line therapies.
PERSONALIZED MEDICINE
APOL1 and Cardiovascular Disease Among African Americans
Million Veteran Program lends statistical power to assess genetic risk.
Patient Perceptions of Genomic Medicine
Common themes emerge from genomic medicine interventions.
Atlas Initiative to Map Colorectal Adenoma Progression
Moonshot project explores the microbiome for pathways from pre-polyp to malignancy.
NIH’s “All of Us” Data Browser Unveiled
Researchers can access aggregate survey and EHR data from 100,000 participants—and counting.
Assessing Liquid Biopsies for Precision Cancer Care
Evaluating the potential to impact diagnosis and treatment.
Landmark GWAS Catalogs Blood Pressure Risk in 775,000+ Patients
Extensive catalog of genetic variants tied to BP opens doors to new therapies.
First-time PHEWAS Study Shows Men at Greater AFib Risk
Large-scale EHR analysis reveals key differences in SLE outcomes and treatment responses.
Mapping CKD Complications to Unexpected Genetic Locations
New meta-analysis integrates seven genome-wide association studies to explain FGF23 elevations.
Using PET Imaging to Expedite Precision Cancer Medicine
VU-PREDICT initiative leverages PET for radiopharmaceutical and cancer drug development.
ADVANCING WOMEN'S HEALTH
